Combination Therapy With Sitagliptin and Lansoprazole to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes



Status:Archived
Conditions:Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:August 2010
End Date:April 2014

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Combination Therapy With Sitagliptin (DPP 4 Inhibitor) and Lansoprazole (PPI) Inhibitor) to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes


Sanford Research/USD proposes to study the combination therapy of oral administration of
sitagliptin and lansoprazole versus placebo for the preservation of pancreatic beta cells
still present in patients with recent-onset diabetes and possibly regenerating their beta
cells, while safely down-regulating the autoimmune response directed against the beta cells.



We found this trial at
1
site
Sanford Research/USD
Sioux Falls, South Dakota 57104
?
mi
from
Sioux Falls, SD
Click here to add this to my saved trials